drugset / Trial / NCT00784940
ATAC - Bone Density Sub-Protocol
RandomizedParallel-groupDouble-blind
Summary
To assess and quantify the changes in bone mineral density between the ARIMIDEX and ARIMIDEX plus NOLVADEX groups when compared to the NOLVADEX alone treatment group whilst receiving trial therapy.
Timeline
- Start
- 1998-06
- Primary completion
- 2005-03
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Anastrozole | Other / unclassified | 1 mg | Oral |
| Comparator | Tamoxifen | Small molecule | 20 mg | Oral |